teresina laragione baylor college of medicine email

Grad Initiative and T32 award GM088129 from the National Institutes of Health. Received: Revised: Accepted: Sep 11, 2014 Through the copyediting, typesetting, pagination and proofreading process which may lead toĭifferences between this version and the Version of Record. This article has been accepted for publication and undergone full peer review but has not been was supported by the Howard Hughes Medical Institutes Med into and F.T.H.) and an Award in Experimental Therapeutics from the Alkekįoundation and the Baylor College of Medicine Institute for Clinical and Translational Research *These authors contributed equally to this work.Īcknowledgements: This work was supported through funding from Baylor College of

Hospital for Special Surgery, New York, NY10021ĭivision of Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029 Graduate program in Molecular Physiology and Biophysics, Baylor College of Medicine, Interdepartmental Graduate Program in Translational Biology and Molecular Medicine, BaylorĬollege of Medicine, Houston, TX 77030, USA Horrigan PhD1, Pércio S.ĭepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Khan BSc1, Teresina Laragione PhD4, Frank T. Tanner BA1,2*, Xueyou Hu PhD1*, Redwan Huq BSc1,3, Rajeev B. Title: KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates rat Running head: Targeting KCa1.1 channels in animal models of RA

Teresina laragione baylor college of medicine email